Platelet factor 4 (PF4) is a small cytokine belonging to the CXC chemokine family that is also known as chemokine (C-X-C motif) ligand 4 (CXCL4) .
This chemokine is released from alpha-granules of activated platelets during platelet aggregation, and promotes blood coagulation by moderating the effects of heparin-like molecules.
It is a chemokine found within the platelet alpha granules and lining the glycocalyx of endothelial cells and has a potential role in inflammatory processes and antimicrobial host defense.
It plays a role in wound repair and inflammation, and usually found in a complex with proteoglycan.
The gene for human PF4 is located on human chromosome 4.
Platelet factor-4 is a 70-amino acid protein.
It is released from the alpha-granules of activated platelets and binds with high affinity to heparin.
It consists of 4 70 amino acid monomers, each bearing several positively charged amino acids, whose structural features are key to the pathogenesis of anti-PF4 disorders through the formation of pathogenic immune complexes, for which the tetramer nature of PS4 is essential.
Its major physiologic role appears to be neutralization of heparin-like molecules on the endothelial surface of blood vessels, thereby inhibiting local antithrombin activity and promoting coagulation.
It is a strong chemoattractant for neutrophils and fibroblasts, and probably has a role in inflammation and wound repair.
PF4 is chemotactic for neutrophils, fibroblasts and monocytes, and interacts with a variant of the chemokine receptor CXCR3, known as CXCR3-B.
The heparin:PF4 complex is the antigen in heparin-induced thrombocytopenia (HIT), an idiosyncratic autoimmune reaction to the administration of the anticoagulant heparin.
PF4 autoantibodies have also been found in patients with thrombosis and features resembling HIT but no prior administration of heparin.
Antibodies against PF4 have been implicated in cases of thrombosis and thrombocytopenia subsequent to vaccination with the COVID-19 vaccine- vaccine-induced immune thrombotic thrombocytopenia (VITT).
Changes in the expression of PF4 have also been associated with symptoms of long COVID.
It is increased in patients with systemic sclerosis that also have interstitial lung disease.
The human platelet factor 4 kills malaria parasites within erythrocytes by selectively lysing the parasite’s digestive vacuole.